Annual Accounts Receivable
N/A
December 31, 2023
Summary
- RGLS annual accounts receivable is not available.
Performance
RGLS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- RGLS quarterly accounts receivable is not available.
Performance
RGLS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RGLS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
RGLS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Regulus Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $3000.00(-25.0%) |
| Mar 2023 | - | $4000.00(>+9900.0%) |
| Jun 2022 | - | $0.00(-100.0%) |
| Mar 2022 | - | $8000.00(>+9900.0%) |
| Sep 2021 | - | $0.00(-100.0%) |
| Jun 2021 | - | $194.00 K(+169.4%) |
| Mar 2021 | - | $72.00 K(-85.7%) |
| Dec 2020 | $503.00 K(-55.9%) | $503.00 K(-87.4%) |
| Sep 2020 | - | $4.00 M(+493.5%) |
| Jun 2020 | - | $674.00 K(-0.3%) |
| Mar 2020 | - | $676.00 K(-40.8%) |
| Dec 2019 | $1.14 M | $1.14 M(+63.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $699.00 K(+111.2%) |
| Jun 2019 | - | $331.00 K(-88.1%) |
| Mar 2019 | - | $2.79 M(>+9900.0%) |
| Dec 2018 | $26.00 K(-93.0%) | $26.00 K(+100.0%) |
| Sep 2018 | - | $13.00 K(-92.9%) |
| Jun 2018 | - | $184.00 K(-2.1%) |
| Mar 2018 | - | $188.00 K(-49.6%) |
| Dec 2017 | $373.00 K(+372.2%) | $373.00 K(+166.4%) |
| Mar 2014 | - | $140.00 K(+77.2%) |
| Dec 2013 | $79.00 K | $79.00 K(-16.8%) |
| Sep 2013 | - | $95.00 K(-96.3%) |
| Jun 2013 | - | $2.54 M |
FAQ
- What is the all time high annual accounts receivable for Regulus Therapeutics?
- What is the all time high quarterly accounts receivable for Regulus Therapeutics?
What is the all time high annual accounts receivable for Regulus Therapeutics?
Regulus Therapeutics all-time high annual accounts receivable is $1.14 M
What is the all time high quarterly accounts receivable for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly accounts receivable is $4.00 M